|
AU649897B2
(en)
|
1991-11-14 |
1994-06-02 |
Women's And Children's Hospital |
Synthetic alpha-L-iduronidase and genetic sequences encoding same
|
|
US6149909A
(en)
|
1995-06-23 |
2000-11-21 |
Women's And Children's Hospital |
Synthetic α-L-iduronidase and genetic sequences encoding same
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
AU722624B2
(en)
|
1996-09-06 |
2000-08-10 |
Trustees Of The University Of Pennsylvania, The |
An inducible method for production of recombinant adeno-associated viruses utilizing T7 polymerase
|
|
CA2328518A1
(en)
|
1998-05-13 |
1999-11-18 |
Harbor-Ucla |
Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
|
|
PT1916258E
(pt)
|
1999-08-09 |
2014-07-29 |
Genzyme Corp |
Aumento da expressão de uma sequência nucleotídica heteróloga de cadeia simples a partir de vectores virais recombinantes por concepção da sequência de maneira que esta forme pares de bases intracadeia
|
|
US6426208B1
(en)
|
1999-11-12 |
2002-07-30 |
Harbor-Ucla Research And Education Institute |
Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
|
|
RU2196988C2
(ru)
|
2000-04-19 |
2003-01-20 |
Государственный новосибирский областной клинический диагностический центр |
Способ диагностики мукополисахаридозов
|
|
AU2001267337A1
(en)
|
2000-06-30 |
2002-01-14 |
Maxygen Aps |
Peptide extended glycosylated polypeptides
|
|
NZ532635A
(en)
|
2001-11-13 |
2007-05-31 |
Univ Pennsylvania |
A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
AU2003302724A1
(en)
|
2002-08-13 |
2004-07-09 |
Mcivor, Scott, R. |
Methods of using vectors to treat metabolic disorders
|
|
US7155804B2
(en)
|
2003-09-17 |
2007-01-02 |
Moog Inc. |
Method of forming an electric motor
|
|
CN1856576B
(zh)
|
2003-09-30 |
2011-05-04 |
宾夕法尼亚州立大学托管会 |
腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
|
|
WO2006110689A2
(en)
|
2005-04-07 |
2006-10-19 |
The Trustees Of The University Of Pennsylvania |
Method of increasing the function of an aav vector
|
|
EP1777906A1
(en)
|
2005-06-09 |
2007-04-25 |
Matsushita Electric Industrial Co., Ltd. |
Amplitude error compensating apparatus and orthogonality error compensating apparatus
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
US20090062144A1
(en)
|
2007-04-03 |
2009-03-05 |
Nancy Lan Guo |
Gene signature for prognosis and diagnosis of lung cancer
|
|
US9415121B2
(en)
|
2008-12-19 |
2016-08-16 |
Nationwide Children's Hospital |
Delivery of MECP2 polynucleotide using recombinant AAV9
|
|
JP2014503173A
(ja)
|
2009-11-05 |
2014-02-13 |
プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ |
制御された発現系
|
|
US20130023033A1
(en)
|
2010-03-29 |
2013-01-24 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
EP2826860B1
(en)
|
2010-04-23 |
2018-08-22 |
University of Massachusetts |
CNS targeting AAV vectors and methods of use thereof
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
EP2394667A1
(en)
|
2010-06-10 |
2011-12-14 |
Laboratorios Del Dr. Esteve, S.A. |
Vectors and sequences for the treatment of diseases
|
|
DK2675902T3
(da)
|
2011-02-17 |
2019-06-03 |
Univ Pennsylvania |
Sammensætninger og fremgangsmåder til at ændre vævsspecificitet og forbedre aav9-medieret genoverførsel
|
|
HRP20171334T1
(hr)
|
2011-04-22 |
2017-11-17 |
The Regents Of The University Of California |
Virioni adeno-povezanog virusa s kapsid varijantom i postupci njihove upotrebe
|
|
DK3444342T3
(da)
|
2012-07-11 |
2020-08-24 |
Sangamo Therapeutics Inc |
Fremgangsmåder og sammensætninger til behandlingen af lysosomale aflejringssygdomme
|
|
WO2014125647A1
(ja)
|
2013-02-18 |
2014-08-21 |
富士通オプティカルコンポーネンツ株式会社 |
光受信装置
|
|
SI2984166T1
(sl)
|
2013-03-15 |
2020-09-30 |
The Trustees Of The University Of Pennsylvania |
Sestavki za zdravljenje MPSI
|
|
CN105377039A
(zh)
|
2013-05-15 |
2016-03-02 |
明尼苏达大学董事会 |
腺相关病毒介导的基因向中枢神经系统转移
|
|
CA2915296A1
(en)
|
2013-06-11 |
2015-02-26 |
Portage Pharmaceuticals Ltd. |
Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
|
|
US9585971B2
(en)
|
2013-09-13 |
2017-03-07 |
California Institute Of Technology |
Recombinant AAV capsid protein
|
|
WO2015164723A1
(en)
|
2014-04-25 |
2015-10-29 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for treating metastatic breast cancer and other cancers in the brain
|
|
BR112017005892A2
(pt)
|
2014-09-24 |
2017-12-12 |
Hope City |
variantes de vetor de vírus adeno-associado para edição de genoma de alta eficácia e métodos da mesma
|
|
CN107002096A
(zh)
|
2014-10-06 |
2017-08-01 |
阿罗根有限公司 |
基于aav的基因疗法
|
|
HK1256341A1
(zh)
*
|
2015-05-15 |
2019-09-20 |
明尼苏达大学董事会 |
用於治疗性递送到中枢神经系统的腺相关物
|
|
US10604747B2
(en)
*
|
2015-08-06 |
2020-03-31 |
Academia Sinica |
Engineered enzyme for enzyme replacement therapy
|
|
EP3332012A4
(en)
|
2015-08-06 |
2019-01-16 |
The Trustees of The University of Pennsylvania |
GLP-1 AND USE THEREOF IN COMPOSITIONS FOR THE TREATMENT OF METABOLISM DISEASES
|
|
US20170059692A1
(en)
|
2015-08-28 |
2017-03-02 |
Laufer Wind Group Llc |
Mitigation of Small Unmanned Aircraft Systems Threats
|
|
HK1257024A1
(zh)
*
|
2015-08-31 |
2019-10-11 |
宾夕法尼亚大学 |
用於治疗伴侣动物的aav-epo
|
|
US20180236105A1
(en)
*
|
2015-10-23 |
2018-08-23 |
University Of Iowa Research Foundation |
Methods for treating neurodegenerative diseases using gene therapy to delay disease onset and progression while providing cognitive protection
|
|
WO2017100676A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav8
|
|
EP3387138B1
(en)
|
2015-12-11 |
2022-01-26 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav9
|
|
US11028372B2
(en)
|
2015-12-11 |
2021-06-08 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAVRH10
|
|
US11015173B2
(en)
|
2015-12-11 |
2021-05-25 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV1
|
|
CA3010738A1
(en)
*
|
2016-01-15 |
2017-07-20 |
Sangamo Therapeutics, Inc. |
Methods and compositions for the treatment of neurologic disease
|
|
EP3411488A1
(en)
|
2016-02-03 |
2018-12-12 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for treating mucopolysaccharidosis type i
|
|
EP3541946A1
(en)
|
2016-11-15 |
2019-09-25 |
Regents Of The University Of Minnesota |
Method for improving neurological function in mpsi and mpsii and other neurological disorders
|
|
CA3049915A1
(en)
|
2017-01-31 |
2018-08-09 |
Stephen YOO |
Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)
|
|
MA50016A
(fr)
|
2017-07-06 |
2020-07-08 |
Univ Pennsylvania |
Thérapie génique médiée par aav9 pour traiter la mucopolysaccharidose de type i
|
|
IL280198B2
(en)
|
2018-07-18 |
2026-01-01 |
Regenxbio Inc |
Treatment of mucopolysaccharidosis I with fully glycosylated human iduronidase-alpha-L (idus)
|
|
WO2021150570A1
(en)
|
2020-01-22 |
2021-07-29 |
Regenxbio Inc. |
Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)
|
|
WO2022170082A1
(en)
|
2021-02-05 |
2022-08-11 |
Regents Of The University Of Minnesota |
Methods for preventing cardiac or skeletal defects in diseases including mucopolysaccharidoses
|